Business Context and Reporting Period
This Form 8-K is a current report filed by NanoVibronix, Inc. (not Envue Medical, Inc.) on October 30, 2025. The registrant is incorporated in Delaware and its common stock trades on the Nasdaq Capital Market under the symbol NAOV. The report addresses Item 5.02 regarding the departure of directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report focused on corporate governance changes and does not contain financial statements or performance data.
Material Changes
The material change reported is the resignation of four directors from the Board of Directors and all associated committees, effective immediately prior to the 2025 Annual Meeting of Stockholders. The departing directors are:
- Christopher Fashek (Audit, Nominating and Corporate Governance, and Compensation Committees)
- Thomas Mika (Audit and Compensation Committees)
- Martin Goldstein, M.D. (Nominating and Corporate Governance Committee)
- Brian Murphy
The Company states these departures are for personal reasons and did not result from any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on future performance. No specific risks or contingencies related to the resignations were disclosed beyond the standard statement that the departures were not due to disagreements.
Investor Verification Checklist
- Verify the composition of the Board of Directors following the resignations and the appointment of any new directors.
- Confirm the status of the Audit, Nominating, and Compensation Committees to ensure quorum and compliance with Nasdaq listing standards.
- Review the upcoming 2025 Annual Meeting of Stockholders materials for any related proposals or changes in governance structure.
- Check for any subsequent filings (e.g., 10-Q or 10-K) to obtain the Company's actual financial performance metrics, as they are absent from this 8-K.